India Contraceptive Devices Market - Growth, Trends, and Forecasts (2023-2028)

The Indian Contraceptives Devices market is projected to grow at a CAGR of 7.42% during the forecast period.

COVID-19 had a significant impact on the growth of the market. The sales of contraceptive devices dropped notably due to the strict lockdown regulations, which also halted the sales of contraceptive devices. According to a report by the Condom Alliance 2020, condom sales in the country fell 48 % during the lockdown period in 2020, with a projected full-year decline of 35% for FY2021. Thus, COVID-19 had a significant impact on the market. However, the relaxation of the lockdown restrictions restored the normal supply chain functioning of the contraceptive device. This is expected to contribute to the market's growth over the coming five years.

The key factors leading to the development of the contraception industry in India are the imperative of reducing unplanned pregnancies and their consequences. One of the major drivers for this demand is the need to prevent unwanted pregnancies, particularly among teenage women. According to the NCBI article published in October 2021, untended pregnancy in India was 11.9%. Additionally, the article published in Tatsat chronicle in April 2022 mentioned that one in seven unwanted pregnancies occur annually in India. Thus, India's rising number of unintended pregnancies is expected to boost the market for contraceptive devices.

Furthermore, the launch of innovative product lines by the market players also propels the market's growth. For instance, in September 2021, Durex launched one of the first-ever 'Made for India' innovations with Durex Extra-Thin Flavoured Condoms. This is one of Durex's most customer-focused innovations in the flavored condom category.

However, the side effects associated with using contraceptives and the high cost of treatment may impede the market's growth.

India Contraceptive Devices Market Trends

Condoms Segment is Expected to Hold Significant Market Share in the India Contraceptive Devices Market Over the Forecast Period

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use significantly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. The other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population.

According to the National AIDS Control Organization August 2022 Report, in India, 24.1 Lakhs of adults are living with HIV and 1.70 lakh young people aged 15-24 years are living with HIV. The report also mentioned that nearly 62.97 thousand new HIV cases among adults were diagnosed in 2021. Thus, increasing the prevalence of HIV across India boosts the demand for condoms, thereby augmenting the segment's growth.

Additionally, in recent years, the campaigns promoted by various companies are also raising awareness on the usage of condoms in the country. For instance, in June 2022, Manforce Condoms, a condom brand from the house of Mankind Pharma, rolled out the #TravelWithManforce campaign. Through this campaign, the company is spreading the message of having safe sex. Such awareness campaigns are also anticipated to drive the segment's growth further.

Hence, all these factors are expected to contribute to the segment's growth during the forecast period.

Intra Uterine Devices is Expected to Hold Notable Market Share in the India Contraceptive Devices Market Over the Forecast Period

Intrauterine devices (IUDs) are small contraceptive devices inserted into the uterus to prevent pregnancy. Copper and hormonal IUDs are its two types.

Factors such as growing awareness and increasing usage of IUDs in India are expected to contribute to the growth of the studied segment. For instance, in the NCBI article published in June 2021, 1.5% of currently married Indian women were using intrauterine devices, and 2.54 million women adopted IUDs in the postpartum period comprising approximately 45% of the total IUD insertions. The article also mentioned that IUD continuation increased significantly in cases where partners jointly selected the method compared to situations where the woman decided alone. The increasing usage of IUDs is expected to fuel the growth of the studied segment.

Likewise, the article published in Engender Health in 2021 mentioned that approximately 3% of women selected the IUS as their method of choice for contraception. Thus, the high adoption of IUDs is also expected to contribute to the market's growth.

Furthermore, the rapidly increasing population and high fertility rates in India are also expected to raise the demand for IUDs, thereby contributing to the growth of the studied segment. For instance, the report published by the Ministry of Health and Family Welfare in July 2022 mentioned that the current total fertility rate for India is 2.0%, and over five states in India have high fertility rates.

Thus, the high adoption and increasing usage of IUDs and high fertility rates in India are expected to contribute to the growth of the studied segment over the forecast period.

India Contraceptive Devices Market Competitor Analysis

The India contraceptive devices market is competitive and consists of several players. In terms of market share, a few major players dominate the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Companies currently dominating the market are Bayer AG, Mayer Laboratories, Inc., Reckitt Benckiser Group plc, CooperSurgical, Inc., and AbbVie Inc. (Allergan PLC).

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.